AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 746-752, November 2009

A prospective study of the impact of colonization following hospital admission by glycopeptide-resistant Enterococci on mortality during a hospital outbreak

  • Alexis Hautemanière, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • Nancy Université, Vandoeuvre les Nancy, France
    • Inserm Eri 11, Vandoeuvre les Nancy, France
    • Corresponding Author InformationAddress correspondence to A. Hautemanière MD, PhD, professor associate, Département Environnement et Santé Publique-S.E.R.E.S., Faculté de Médecine, 9 Avenue de la Forêt de Haye, B.P. 184, 54505 Vandoeuvre-les-Nancy, France.
  • ,
  • Paul R. Hunter, MD, PhD

      Affiliations

    • Nancy Université, Vandoeuvre les Nancy, France
    • School of Medicine, Health Policy and Practice University of East Anglia, Norwich, England
  • ,
  • Nathalie Diguio, MD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
  • ,
  • Elaine Albuisson, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • Nancy Université, Vandoeuvre les Nancy, France
  • ,
  • Philippe Hartemann, MD, PhD

      Affiliations

    • Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France
    • Nancy Université, Vandoeuvre les Nancy, France
    • Inserm Eri 11, Vandoeuvre les Nancy, France

published online 25 June 2009.

Background

This study was designed to investigate the impact on mortality of colonization by glycopeptide-resistant Enterococci (GRE) during hospitalization.

Methods

Between 2004 and 2006, a hospital in Nancy, France, was subject to a GRE van A outbreak. Some 113 patients who had acquired GRE after hospital admission were matched with 113 controls. Basic demographic data, such as sex, age, principal pathology, history of surgery, and presence of associated pathology, were obtained for each case and control. Information on whether or not the case subject was still alive was obtained by searching the hospital mortality database and the civil death register and by phoning the patient's home. Statistical analysis used the Cox proportional hazards model for calculating survival function with SPSS software version 9.1 (SPSS Inc., Chicago, IL).

Results

The mean age was 71.2 in the GRE+ group and 70.8 in the control group (P = .80). There was a significant difference between the groups for severity status health (P = .035). The mortality rate was 30.1% in the case group and 19.5% in the control group. Single predictor variable analysis showed a hazard ratio of death in the case group of 4.61 (95% confidence interval [CI]: 2.58-8.28], P = 2 × 10-7). The final Cox regression model with multiple predictor variables showed that only GRE presence (OR, 1.63 [95% CI: 1.04-2.57], P = .035) and severity of comorbidity (P = .013) were independently significant predictors of mortality.

Conclusion

This study shows that the GRE acquisition has a poor prognosis and that this is independent of the other prognostic factors such as age and severity of underlying disease. Survival in GRE+ patients was significantly shorter.

Key Words: Mortality, glycopeptide's-resistance Enterococcus, survey data, cross contamination, nosocomial colonization

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest: None to report.

PII: S0196-6553(09)00424-6

doi:10.1016/j.ajic.2009.02.007

AJIC: American Journal of Infection Control
Volume 37, Issue 9 , Pages 746-752, November 2009